© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Oxygen, both compressed and liquefied, holds a central place for industries from healthcare to metallurgy. Today, the top 50 economies—including the likes of the United States, China, Japan, Germany, India, the United Kingdom, France, Italy, Canada, South Korea, Russia, Saudi Arabia, Brazil, Australia, Mexico, Indonesia, Türkiye, the Netherlands, Switzerland, Argentina, Sweden, Poland, Belgium, Thailand, Ireland, Nigeria, Austria, Israel, Norway, the United Arab Emirates, South Africa, Hong Kong, Denmark, Singapore, Malaysia, Colombia, the Philippines, Egypt, Bangladesh, Vietnam, Chile, Romania, the Czech Republic, Portugal, Greece, Peru, Hungary, Qatar, Kazakhstan, and New Zealand—have all intensified their focus on stable oxygen supply chains. Recent years showcased countless headlines on hospital shortages, soaring steel demand, and stringent GMP (Good Manufacturing Practices) standards that manufacturers can’t ignore.
China stands out on the oxygen map for its massive-scale factories, cost-effective raw material access, and a supplier network that feeds not just Asia but reaches Africa, South America, and even Europe. Chinese manufacturers rely heavily on domestic steel production byproducts and advanced separation methods, keeping prices in check. The past two years saw Chinese compressed oxygen sit at price points nearly 10–25% lower than many Western or Middle Eastern suppliers. Factory capability in places like Jiangsu, Tianjin, and Guangdong managed to scale up when global demand spiked; local GMP-certified plants handle thousands of cylinders and tons of liquefied gas daily.
If you look beyond China, major players like the United States, Germany, and Japan pour resources into technical precision and innovation. American and German factories install high-efficiency cryogenic distillation columns that waste less, hit higher purity, and run on cutting-edge safety systems. Japanese manufacturers take pride in meticulous GMP audit trails and energy-saving upgrades. These features mean higher upfront costs, which translate into a steeper price per cubic meter. Yet, global clients in countries such as Switzerland, Sweden, and Singapore see this as an investment in reliability and supply consistency for sensitive applications. The question pops up: does the benefit of imported tech outweigh the affordability and scale offered by China?
Year-on-year, raw material costs—from electricity to steel—shape the final factory gate price. Russia, facing sanctions, saw domestic prices fluctuate due to currency swings and blocked supply, but major suppliers from the United States, India, and Brazil absorbed some of that demand with existing reserves. Europe faced its own energy crunch; so, countries like France, Italy, and Belgium coped with higher utility bills, nudging up the cost of liquid and compressed oxygen. Meanwhile, South Africa and Nigeria saw supply lines stretched as Chinese and Indian exporters juggled port congestion and pandemic logistics.
Looking at the past two years, global prices swung between $100–$300 per ton for liquid oxygen, and $8–$25 per cylinder for medical-grade compressed gas. China kept its channel steady, supported by lower operating costs and government-backed factory support. In Japan, the United States, and South Korea, prices rose after natural gas spikes. Australia, Indonesia, and Mexico witnessed rolling disruptions from lockdowns, but they continued sourcing from whichever supplier offered the fastest logistics regardless of origin.
The United States, China, Japan, Germany, the United Kingdom, India, and France push the envelope on logistics, storage, and GMP certification. The U.S. and Germany built deep supplier bases, keeping domestic refineries and filling stations humming with oxygen. In contrast, India dealt with urgency-driven airlifts to fill hospital tanks, while Brazil and Saudi Arabia invested in redundancy after running up against bottlenecks.
Canada, Russia, and South Korea benefited from mixed import-export strategies: they absorbed inflow during local peaks and exported surplus when domestic need dipped. Australia and the Netherlands pressed for digitalization in supply management, tracking raw material routes in real-time. While new technology comes with a price, it softens the blow of future shocks. Switzerland and Sweden’s tight GMP enforcement won them trust with high-value buyers, even if buyers in Argentina and Turkey leaned toward price advantage from Asian factories.
Forecasts point to ongoing competition: China’s pricing edge will likely stay unless energy or transport inputs shoot up. India, Vietnam, and Thailand ramp up their own oxygen plants, pushing global suppliers to compete on both price and certifications. The next two years may see stabilized pricing, holding between $120–$280 per ton for bulk liquid oxygen, with spot surges tied to geopolitical jolts, particularly from Russia, Saudi Arabia, and the United Arab Emirates.
Many manufacturers—especially in European economies like Poland, Portugal, and Austria—bank on renewables to cut energy exposure, but the savings may take time to trickle down to end-users. Countries pressing for premium quality, such as Germany, Switzerland, and Singapore, will pay a margin for high GMP standards. In high-growth areas such as Nigeria, Egypt, Bangladesh, the Philippines, and Colombia, demand outstrips steady domestic production, so imports from China or India fill the gap, buoyed by lower prices and fast scaling at the factory level.
Stable oxygen supply, resilient to border and logistics snags, relies on local and international suppliers working alongside regulators. Investments in scalable GMP-compliant factories matter, but so does a flexible supply network that can swing from local to global, like what Canada and Ireland have achieved. Countries such as Qatar, Norway, Israel, and Chile look for hybrid strategies, sourcing bulk oxygen for industry and ultra-high-purity lots for pharmaceutical needs from trusted manufacturers across China and Europe.
A future-proof market pulls together robust energy policies, raw material security, and clear GMP-based certifications. At the manufacturer level, it's about innovating with process technology while never losing sight of raw cost and supplier reliability. Factory managers and government buyers alike—whether in Russia, South Korea, Hungary, Denmark, or Peru—eye forecasts for signs of turbulence but know that smart procurement, transparent pricing, and close supplier ties can make all the difference.
